Transcriptional consequences of autosomal trisomy: primary gene dosage with complex downstream effects.
暂无分享,去创建一个
[1] J. Birchler,et al. Dosage-dependent gene regulation in multicellular eukaryotes: implications for dosage compensation, aneuploid syndromes, and quantitative traits. , 2001, Developmental biology.
[2] Katheleen Gardiner,et al. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. , 2003, Gene.
[3] R. Behringer,et al. Tetraploid development in the mouse , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[4] L. Personnaz,et al. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. , 2005, Human molecular genetics.
[5] R. Reeves,et al. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. , 2003, Human molecular genetics.
[6] S. South,et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. , 2004, Genome research.
[7] N. Hastie,et al. Transcriptome analysis of human autosomal trisomy. , 2002, Human molecular genetics.
[8] K. Spencer,et al. First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects , 1993, Prenatal diagnosis.
[9] Joan T Richtsmeier,et al. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. , 2002, American journal of medical genetics.
[10] M. Petersen,et al. Nondisjunction in trisomy 21: Origin and mechanisms , 2001, Cytogenetic and Genome Research.
[11] K. Yamakawa,et al. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. , 2004, Human molecular genetics.
[12] C. Epstein,et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Jacobs,et al. A cytogenetic study of 1000 spontaneous abortions , 1980, Annals of human genetics.
[14] Stylianos E. Antonarakis,et al. Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.
[15] A. Hackshaw,et al. Revised distribution parameters for serum markers for trisomy 18 , 2000, Journal of Medical Screening.
[16] Yang Liu,et al. Mouse Brain Organization Revealed Through Direct Genome-Scale TF Expression Analysis , 2004, Science.
[17] R. Bronson,et al. A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.
[18] C. Cooke‐Yarborough,et al. Karyotype, phenotype and parental origin in 19 cases of triploidy , 2001, Prenatal diagnosis.
[19] J T Richtsmeier,et al. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. , 2000, Human molecular genetics.
[20] S. Antonarakis,et al. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. , 2004, Genome research.
[21] J. Birchler,et al. Dosage effects on gene expression in a maize ploidy series. , 1996, Genetics.
[22] Jonathan Pevsner,et al. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. , 2003, Genomics.